GlycoMimetics, Inc. (GLYC)
NASDAQ: GLYC · Real-Time Price · USD
0.2100
+0.0010 (0.48%)
At close: Jun 4, 2025, 4:00 PM
0.2128
+0.0028 (1.33%)
After-hours: Jun 4, 2025, 7:42 PM EDT
GlycoMimetics Employees
GlycoMimetics had 4 employees as of December 31, 2024. The number of employees decreased by 31 or -88.57% compared to the previous year.
Employees
4
Change (1Y)
-31
Growth (1Y)
-88.57%
Revenue / Employee
n/a
Profits / Employee
-$7,371,557
Market Cap
13.55M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
| AbbVie | 55,000 |
GLYC News
- 6 days ago - Crescent Biopharma to Present at the Jefferies Global Healthcare Conference - GlobeNewsWire
- 19 days ago - GLYCOMIMETICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of GlycoMimetics, Inc. - GLYC - Business Wire
- 5 weeks ago - Crescent Biopharma Appoints David Lubner to Board of Directors - GlobeNewsWire
- 2 months ago - Crescent Biopharma Appoints Joshua Brumm as Chief Executive Officer and Expands Leadership Team to Advance Pipeline of Potentially Best-in-Class Oncology Therapeutics - GlobeNewsWire
- 3 months ago - SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CMRX and GLYC on Behalf of Shareholders - PRNewsWire
- 3 months ago - Crescent Biopharma to Present at the TD Cowen 45th Annual Health Care Conference - GlobeNewsWire
- 7 months ago - Crescent Biopharma to Present at Jefferies London Healthcare Conference 2024 - PRNewsWire
- 7 months ago - GlycoMimetics Announces New Uproleselan Clinical Data Will Be Presented at ASH Annual Meeting - Business Wire